2021 Opens With Growth And Improved Profitability PR Newswire STOCKHOLM, May 7, 2021 STOCKHOLM, May 7, 2021 /PRNewswire/ -- FIRST QUARTER 2021 Order intake amounted to 66.3 (47.7) MSEK...
Reminder: C-RAD Web Presentation Interim Report Q1 2021 and AGM speech PR Newswire STOCKHOLM, May 4, 2021 STOCKHOLM, May 4, 2021 /PRNewswire/ -- Invitation to join the presentation of C-RAD's...
The Patent and Market Court of Appeal issues judgement confirming C-RAD's entitlement to Beamocular's invention PR Newswire STOCKHOLM, April 23, 2021 STOCKHOLM, April 23, 2021 /PRNewswire/ -- The...
C-RAD Web Presentation Interim Report Q1 2021 and AGM speech PR Newswire STOCKHOLM, April 23, 2021 STOCKHOLM, April 23, 2021 /PRNewswire/ -- Invitation to join the presentation of C-RAD's first...
Alliance radiation oncology at Anna Jaques hospital becomes a C-RAD total-integration customer PR Newswire STOCKHOLM, Feb. 22, 2021 STOCKHOLM, Feb. 22, 2021 /PRNewswire/ -- C-RAD and Alliance...
C-RAD and WITH-GLOBAL engage in a partnership for the South Korean market C-RAD signed a distribution agreement with the South Korean company WITH-GLOBAL to cover sales and service in the local...
Record order intake and revenue leads to increased profit for the quarter and full year : C-RAD PR Newswire STOCKHOLM, Jan. 28, 2021 STOCKHOLM, Jan. 28, 2021 /PRNewswire/ -- FOURTH QUARTER 2020...
C-RAD Web Presentation Year-end Report 2020 PR Newswire STOCKHOLM, Jan. 18, 2021 STOCKHOLM, Jan. 18, 2021 /PRNewswire/ -- Invitation to join the presentation of C-RAD's fourth quarter 2020 Date:...
C-RAD receives order for proton cancer treatment centers in the US PR Newswire STOCKHOLM, Dec. 28, 2020 STOCKHOLM, Dec. 28, 2020 /PRNewswire/ -- C-RAD announces today that C-RAD has been selected...
Shenzhen proton therapy treatment center selects C-RAD Catalyst™ system PR Newswire STOCKHOLM, Dec. 23, 2020 STOCKHOLM, Dec. 23, 2020 /PRNewswire/ -- C-RAD has now received the purchase order...
Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 34.15 | 34.15 | 34.15 | 212 | 34.15 | DE |
4 | 0 | 0 | 34.15 | 34.15 | 34.15 | 256 | 34.15 | DE |
12 | 0 | 0 | 34.15 | 34.15 | 34.15 | 2072 | 34.15 | DE |
26 | 0 | 0 | 34.15 | 34.15 | 34.15 | 1036 | 34.15 | DE |
52 | 0 | 0 | 34.15 | 34.15 | 34.15 | 913 | 34.15 | DE |
156 | 0 | 0 | 34.15 | 34.15 | 34.15 | 350 | 34.15 | DE |
260 | 0 | 0 | 34.15 | 34.15 | 34.15 | 238 | 34.15 | DE |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales